
Candel Therapeutics, Inc.
CADLHealthcare|Biotechnology|US
$8.75
+0.71 (+8.83%)
DCF Value
$2.20
Tangible Book / Share
$1.70
Cash / Share
$2.72
Ownership Breakdown
78.7%
Float
76.5M
Shares Outstanding
60.2M
Float Shares
Major Holders (17)
Combined: 97.6%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| FMR LLC | Holding company | 15.00% | 6,318,721 | Feb 7, 2025 | 13D/G |
| Abigail P. Johnson | Individual | 9.30% | 3,923,599 | Feb 7, 2025 | 13D/G |
| RTW Investments, LP | IA, PN | 8.80% | 6,422,018 | May 15, 2026 | 13D/G |
| Roderick Wong | HC, IN | 8.80% | 6,422,018 | May 15, 2026 | 13D/G |
| Paul B Manning | Individual | 7.90% | 5,790,999 | Mar 18, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 6.60% | 4,834,899 | Jul 27, 2026 | 13D/G |
| Anders Hove | Individual | 5.20% | 2,580,517 | Jun 30, 2025 | 13D/G |
| Baker Bros. Advisors (GP) LLC | HC, OO | 4.99% | 2,455,108 | May 15, 2025 | 13D/G |
| Felix J. Baker | HC, IN | 4.99% | 2,455,108 | May 15, 2025 | 13D/G |
| Baker Bros. Advisors LP | IA, PN | 4.99% | 2,455,108 | May 15, 2025 | 13D/G |
| Julian C. Baker | HC, IN | 4.99% | 2,455,108 | May 15, 2025 | 13D/G |
| The Paul B. Manning Revocable Trust dated May 10, 2000 | Other | 3.80% | 2,763,527 | Mar 18, 2026 | 13D/G |
| Acorn Bioventures 2, L.P. | Partnership | 3.00% | 1,496,699 | Jun 30, 2025 | 13D/G |
| Acorn Capital Advisors GP2, LLC | Other | 3.00% | 1,496,699 | Jun 30, 2025 | 13D/G |
| Acorn Capital Advisors GP, LLC | Other | 2.20% | 1,083,818 | Jun 30, 2025 | 13D/G |
| Acorn Bioventures, L.P. | Partnership | 2.20% | 1,083,818 | Jun 30, 2025 | 13D/G |
| BKB Growth Investments, LLC | Other | 1.80% | 1,303,752 | Mar 18, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 3,026,955 acquired · 442,692 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ostrovsky Maria | General Counsel | Nov 3, 2026 | AWARD | 315,000 | $8.82 | $2.8M | Form 4 |
| Ostrovsky Maria | Nov 3, 2026 | OTHER | 0 | — | — | Form 4 | |
| Loggia Nicoletta | director | Sep 30, 2026 | AWARD | 380 | $10.44 | $4.0K | Form 4 |
| PAPA JOSEPH C | director | Sep 30, 2026 | AWARD | 1,325 | $10.44 | $13.8K | Form 4 |
| Manning Paul B | director | Sep 30, 2026 | AWARD | 2,189 | $10.44 | $22.9K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Sep 10, 2026 | OPTION EX. | 125,000 | $1.55 | $193.8K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Sep 10, 2026 | OPTION EX. | 125,000 | $1.55 | $193.8K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Sep 10, 2026 | SELL | 220,866 | $11.50 | $2.5M | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Sep 11, 2026 | SELL | 59,379 | $10.46 | $620.9K | Form 4 |
| Zimmermann Martine | director | Sep 8, 2026 | AWARD | 64,000 | $12.60 | $806.4K | Form 4 |
| Zimmermann Martine | Sep 8, 2026 | OTHER | 0 | — | — | Form 4 | |
| Tyagarajan Seshu | Chief Technology Officer | Aug 17, 2026 | SELL | 7,000 | $12.00 | $84.0K | Form 4 |
| Sims Mark E. | Chief Commercial Officer | Jul 6, 2026 | AWARD | 285,000 | $10.03 | $2.9M | Form 4 |
| Sims Mark E. | Jul 6, 2026 | OTHER | 0 | — | — | Form 4 | |
| Barone Francesca | Chief Scientific Officer | Jun 29, 2026 | SELL | 23,447 | $10.06 | $235.8K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Jun 29, 2026 | SELL | 7,000 | $10.02 | $70.2K | Form 4 |
| Manning Paul B | director | Jun 30, 2026 | AWARD | 2,199 | $10.30 | $22.6K | Form 4 |
| PAPA JOSEPH C | director | Jun 30, 2026 | AWARD | 1,331 | $10.30 | $13.7K | Form 4 |
| Loggia Nicoletta | director | Jun 30, 2026 | AWARD | 381 | $10.30 | $3.9K | Form 4 |
| Radhakrishnan Maha | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Loggia Nicoletta | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| PAPA JOSEPH C | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Benz Edward J. JR | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Martell Christopher | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Gaeta Renee | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Nabel Gary J. | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Nguyen Diem | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Manning Paul B | director | Jun 23, 2026 | AWARD | 32,000 | $9.08 | $290.6K | Form 4 |
| Manning Paul B | director | Mar 31, 2026 | AWARD | 4,618 | $4.90 | $22.6K | Form 4 |
| PAPA JOSEPH C | director | Mar 31, 2026 | AWARD | 2,795 | $4.90 | $13.7K | Form 4 |
| Loggia Nicoletta | director | Mar 31, 2026 | AWARD | 779 | $4.90 | $3.8K | Form 4 |
| Manning Paul B | director | Feb 23, 2026 | BUY | 550,458 | $5.45 | $3.0M | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Jan 26, 2026 | AWARD | 154,000 | $6.01 | $925.5K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jan 26, 2026 | AWARD | 136,500 | $6.01 | $820.4K | Form 4 |
| Schoch Charles | Chief Financial Officer | Jan 26, 2026 | AWARD | 232,000 | $6.01 | $1.4M | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Jan 26, 2026 | AWARD | 629,000 | $6.01 | $3.8M | Form 4 |
| Barone Francesca | Chief Scientific Officer | Jan 26, 2026 | AWARD | 232,000 | $6.01 | $1.4M | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jul 28, 2025 | OPTION EX. | 937 | $1.29 | $1.2K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jul 28, 2025 | SELL | 937 | $6.98 | $6.5K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jul 28, 2025 | OPTION EX. | 937 | $1.29 | $1.2K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jun 30, 2025 | OPTION EX. | 781 | $1.29 | $1.0K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jun 30, 2025 | SELL | 781 | $5.04 | $3.9K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jun 30, 2025 | OPTION EX. | 781 | $1.29 | $1.0K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Jun 25, 2025 | AWARD | 5,353 | $4.67 | $25.0K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Jun 25, 2025 | AWARD | 42,826 | $4.67 | $200.0K | Form 4 |
| Manning Paul B | director | Jun 25, 2025 | AWARD | 1,070,663 | $4.67 | $5.0M | Form 4 |
| Martell Christopher | director | Jun 25, 2025 | AWARD | 111,349 | $4.67 | $520.0K | Form 4 |
| Schoch Charles | Chief Financial Officer | Jun 25, 2025 | AWARD | 5,353 | $4.67 | $25.0K | Form 4 |
| Loggia Nicoletta | director | Jun 25, 2025 | AWARD | 2,141 | $4.67 | $10.0K | Form 4 |
| Nabel Gary J. | director | Jun 25, 2025 | AWARD | 5,353 | $4.67 | $25.0K | Form 4 |
| Barone Francesca | Chief Scientific Officer | Jun 25, 2025 | AWARD | 4,282 | $4.67 | $20.0K | Form 4 |
| PAPA JOSEPH C | director | Jun 25, 2025 | AWARD | 64,239 | $4.67 | $300.0K | Form 4 |
| Schoch Charles | Chief Financial Officer | Jun 20, 2025 | AWARD | 50,000 | $4.75 | $237.5K | Form 4 |
| Benz Edward J. JR | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Gaeta Renee | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Loggia Nicoletta | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Manning Paul B | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Martell Christopher | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Nabel Gary J. | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Nguyen Diem | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| PAPA JOSEPH C | director | Jun 17, 2025 | AWARD | 14,240 | $4.94 | $70.3K | Form 4 |
| Radhakrishnan Maha | director | Jun 4, 2025 | AWARD | 28,480 | $5.60 | $159.5K | Form 4 |
| Radhakrishnan Maha | Jun 4, 2025 | OTHER | 0 | — | — | Form 4 | |
| Nichols William Garrett | Chief Medical Officer | Mar 18, 2025 | OPTION EX. | 4,584 | $3.75 | $17.2K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Mar 18, 2025 | OPTION EX. | 13,905 | $1.29 | $17.9K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Mar 18, 2025 | OPTION EX. | 4,584 | $3.75 | $17.2K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Mar 18, 2025 | SELL | 45,316 | $8.76 | $397.0K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Mar 18, 2025 | OPTION EX. | 13,905 | $1.29 | $17.9K | Form 4 |
| Barone Francesca | Chief Scientific Officer | Mar 18, 2025 | OPTION EX. | 18,000 | $1.55 | $27.9K | Form 4 |
| Barone Francesca | Chief Scientific Officer | Mar 18, 2025 | SELL | 32,146 | $8.76 | $281.7K | Form 4 |
| Barone Francesca | Chief Scientific Officer | Mar 18, 2025 | OPTION EX. | 18,000 | $1.55 | $27.9K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Mar 18, 2025 | SELL | 25,772 | $8.77 | $226.0K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Mar 19, 2025 | SELL | 400 | $9.00 | $3.6K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Mar 17, 2025 | OPTION EX. | 20,000 | $1.29 | $25.8K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Mar 17, 2025 | SELL | 31,278 | $8.82 | $275.9K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Mar 17, 2025 | OPTION EX. | 20,000 | $1.29 | $25.8K | Form 4 |
| Schoch Charles | See Remarks | Mar 17, 2025 | SELL | 5,000 | $8.83 | $44.2K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Feb 21, 2025 | DISPOSED | 10,583 | $12.02 | $127.2K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Feb 21, 2025 | DISPOSED | 10,582 | $12.02 | $127.2K | Form 4 |
| Schoch Charles | See Remarks | Feb 12, 2025 | AWARD | 83,000 | $8.55 | $709.7K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Feb 12, 2025 | AWARD | 107,250 | $8.55 | $917.0K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Feb 12, 2025 | AWARD | 65,000 | $8.55 | $555.8K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Feb 12, 2025 | AWARD | 525,000 | $8.55 | $4.5M | Form 4 |
| Barone Francesca | Chief Scientific Officer | Feb 12, 2025 | AWARD | 115,000 | $8.55 | $983.3K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Feb 10, 2025 | DISPOSED | 31,335 | $8.61 | $269.8K | Form 4 |
| Barone Francesca | Chief Scientific Officer | Jan 15, 2025 | SELL | 13,534 | $7.22 | $97.8K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Jan 15, 2025 | SELL | 14,322 | $7.22 | $103.5K | Form 4 |
| Schoch Charles | See Remarks | Jan 15, 2025 | SELL | 9,511 | $7.22 | $68.7K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Jan 15, 2025 | SELL | 21,704 | $7.22 | $156.8K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jan 15, 2025 | SELL | 10,428 | $7.22 | $75.3K | Form 4 |
| Barone Francesca | Chief Scientific Officer | Jan 8, 2025 | SELL | 13,673 | $8.22 | $112.4K | Form 4 |
| Schoch Charles | See Remarks | Jan 8, 2025 | SELL | 9,971 | $8.22 | $81.9K | Form 4 |
| Tak Paul Peter | director, officer: Chief Executive Officer | Jan 8, 2025 | SELL | 21,172 | $8.22 | $174.0K | Form 4 |
| Tyagarajan Seshu | Chief Technology Officer | Jan 8, 2025 | SELL | 14,545 | $8.22 | $119.5K | Form 4 |
| Nichols William Garrett | Chief Medical Officer | Jan 8, 2025 | SELL | 10,799 | $8.22 | $88.7K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Dec 26, 2024 | DISPOSED | 50,000 | $9.01 | $450.5K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Dec 26, 2024 | DISPOSED | 50,000 | $9.01 | $450.5K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Dec 27, 2024 | DISPOSED | 50,000 | $8.85 | $442.5K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Dec 27, 2024 | DISPOSED | 50,000 | $8.85 | $442.5K | Form 4 |
| Aguilar-Cordova Estuardo | 10 percent owner | Dec 20, 2024 | DISPOSED | 100,000 | $9.00 | $900.0K | Form 4 |